Global Ganja Report

Political space for cannabis is generally on the upswing, but there are some intersecting trends that advocates will need to keep a sharp eye on in the coming year. Corporate cannabis will increase pressure on independent producers, while prohibitionists will try to leverage the vape health scare for anti-cannabis propaganda. And the cannabis industry's own terminology may be actually adding to the confusion.

A new study in Canada on cannabis and driving casts doubt on zero-tolerance limits for THC. The study's authors say that THC can indeed impair driving—but that applying laws designed for booze to marijuana is bad science and bad policy.

The higher consciousness associated with the best values of the cannabis community is manifested in Toronto activist Amy Anonymous, who for nine years now has been giving out bags of milk, cookies, warm clothes and (for those who want it) cannabis, to help the city's homeless make it through the harsh Canadian winter.

Bernie Sanders has released his plan for cannabis legalization, which features provisions to keep Big Tobacco from colonizing the new industry. But other exponents of corporate power are already getting a jump on the cannabis sector, and could just as effectively squeeze out independent operators.

There has been significant progress toward cannabis legalization in the United States and globally over the past years, but pockets persist of the most repressive and reactionary prohibition. What are the prospects for expanding cannabis freedom in the coming year?

So-called "smokable hemp" is suddenly available in shops from coast to coast, legal under terms of last year's Farm Bill. But law enforcement is consternated, conservative politicians are apoplectic, and legislation is being prepared to ban the stuff at the state level. Is this permissible under federal law?

Researchers are exploring the connection between cannabinoids and dopamine in the human brain, and particularly how THC affects our "reward system"—key to such phenomena as motivation, addiction and euphoria. Investigations are revealing both potential for treatments of psychiatric disorders as well as possible risks from heavy use, especially among the young.

The US Surgeon General has launched a new campaign hyping the supposed dangers of cannabis—a further disappointment for activists who held out hope that Trump harbored libertarian instincts and would legalize. All too predictably, the anti-legalization assumptions behind the new campaign are amply refuted by actual research.